Proactive Communication about New Medical Technologies: A Brain–Computer Interface Demonstration
MDM Policy & Practice · 2026-07 · 11 (2)
DOI: 10.1177/23814683261486403 ↗Kurz gefasst
Fachartikel in der Zeitschrift MDM Policy & Practice, online erschienen am 20.11.2026. Verfasst von Baruch Fischhoff und 2 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Carnegie Mellon University Professorial Fund of Baruch Fischhoff, National Science Foundation Graduate Research Fellowship Program, Carnegie Mellon University College of Engineering Dean's Fellowship.
Abstract (Originalsprache)
Background
Advances in medical, computer, and engineering science are creating a flood of novel interventions. Their practical value will depend on patients’ ability to decide which are worth adopting. We propose a practical approach, grounded in decision science and US Food and Drug Administration (FDA) procedures, for fulfilling that duty to inform. We illustrate the approach with a brain–computer interface (BCI), a technology that is moving quickly from academic clinical trials to clinical use.
Methods
Our approach adapted the Benefit–Risk Framework (BRF) used by the FDA when evaluating pharmaceuticals and biologics and communicating about those that it approves. We populated the BRF for the BCI demonstration example with responses to semi-structured interviews with physicians, researchers, people with lived experience with paralysis, and caregivers. We employed behavioral science principles to create and evaluate a communication conveying that evidence.
Results
We found that 1) the experts could translate their diverse technical knowledge and lived experience into BRF terms, 2) we could summarize those perspectives in terms that they found accurate, and 3) most members of an online convenience sample, self-identified as having mobility challenges, could understand a communication based on the BRF. Participants who understood the BCI better reported more positive feelings and greater interest in adoption.
Conclusions
With modest effort, authoritative, empirically validated communications can be created for new medical technologies before they become available. When those communications accompany the treatments, they support the moral and legal duty to inform. When they precede the treatments, they avoid leaving a vacuum for unwarranted fears or promises to fill. Proactive communications can help patients make wise choices while protecting public discourse from unwarranted enthusiasm or skepticism.
Förderung
- Carnegie Mellon University Professorial Fund of Baruch Fischhoff
- National Science Foundation Graduate Research Fellowship Program
- Carnegie Mellon University College of Engineering Dean's Fellowship
Zitieren
APA
Fischhoff, B., Collinger, J. L., & Krishnamurti, T. (2026). Proactive Communication about New Medical Technologies: A Brain–Computer Interface Demonstration. MDM Policy & Practice, 11(2). https://doi.org/10.1177/23814683261486403
Vancouver
Fischhoff B, Collinger JL, Krishnamurti T. Proactive Communication about New Medical Technologies: A Brain–Computer Interface Demonstration. MDM Policy & Practice. 2026;11(2). doi:10.1177/23814683261486403
BibTeX
@article{Fischhoff2026,
author = {Fischhoff, Baruch and Collinger, Jennifer L. and Krishnamurti, Tamar},
title = {Proactive Communication about New Medical Technologies: A Brain–Computer Interface Demonstration},
journal = {MDM Policy & Practice},
year = {2026},
volume = {11},
number = {2},
doi = {10.1177/23814683261486403}
}
EUVIMED